Teng-Yue Diao

Teng-Yue Diao

Auto-generated profile, based on publicly available information

Teng-Yue Diao

Center for Systems Biomedical Sciences, University of Shanghai for Science and Technology, Shanghai 200093, China

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in BioMed Research International
Verified
Journal Article
Open access
PDF file
YGYoseph Asmelash Gebru
Yoseph Asmelash Gebru
TDTeng-Yue Diao
Teng-Yue Diao
HPHai Pan
Hai Pan
EMEmmanuel Mukwaya
Emmanuel Mukwaya
YZYan Zhang
Yan Zhang
Metabolic bone disorder is usually caused by abnormalities of minerals and hormones metabolism. Recently, it has been proved by several studies that the renin-angiotensin system (RAS) in local bone tissue is directly involved in bone metabolism. Activation of skeletal RAS plays an important role in bone metabolic disorders. Based onin vitro,in vivo, and clinical studies, this review explains the roles of RAS in bone metabolism and also covers the potential approaches and beneficial effects of RAS inhibition on bone health. Differential strategies for inhibiting RAS can be employed to maintain bone health, which are attributed primarily to the reduced level of angiotensin II (AngII) and suppressed stimulation of the AngII signaling pathway. The use of renin inhibitors, angiotensin-converting enzyme inhibitors, and AngII receptor blockers either individually or in combination with each other could have promising results in fighting bone metabolic disorders associated with other cardiovascular diseases as well as independent bone injuries.